Get started
Author

David Roy Huang

Observed names: David Huang, David R Huang, David R. Huang
Institution: Menwell Limited
ORCID: 0000-0001-8104-6825
Observed ORCID: 0000-0001-8104-6825
OpenAlex ID: A5091576985
Experience and severity of menopause symptoms and effects on health-seeking behaviours: a cross-sectional online survey of community dwelling adults in the United Kingdom
2023 · David Roy Huang, Abigail Goodship, et al. · BMC Women s Health · 80
PDF
Impact of Digital Engagement on Weight Loss Outcomes in Obesity Management Among Individuals Using GLP-1 and Dual GLP-1/GIP Receptor Agonist Therapy: Retrospective Cohort Service Evaluation Study
2025 · Hans Johnson, David Huang, et al. · Journal of Medical Internet Research · 25
PDF
What are community perspectives and experiences around GLP-1 receptor agonist medications for weight loss? A cross-sectional survey study in the UK
2025 · Nadja Auerbach, Vivian N Liu, et al. · BMJ Public Health · 22
PDF
Digital engagement enhances dual GIP / GLP ‐1 receptor agonist and GLP ‐1 receptor agonist efficacy: A retrospective cohort analysis of a digital weight loss service on outcomes and safety
2025 · Hans Johnson, Ashley Kieran Clift, et al. · Diabetes Obesity and Metabolism · 7
PDF
A Virtual Group Consultation Model of Care for Menopause Treatment
2022 · Hannah Gibson, David Huang, et al. · NEJM Catalyst · 7
Digital Engagement Significantly Enhances Weight Loss Outcomes in Adults With Obesity Treated With Tirzepatide: Retrospective Cohort Study of a Digital Weight Loss Service
2025 · Hans Johnson, Ashley Kieran Clift, et al. · Journal of Medical Internet Research · 4
Awareness and prevalence of the symptoms of testosterone deficiency: a cross-sectional survey of community-dwelling men in the UK
2025 · Vivian N Liu, David Roy Huang, et al. · BMJ Open · 2
A cross-sectional survey of experiences and outcomes of using testosterone replacement therapy in UK men
2025 · Austen El-Osta, Vivian N. Liu, et al. · Translational Andrology and Urology · 2
Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study
2026 · Hans Johnson, Daniel Reisel, et al. · Research Square
PDF
Beyond Weight Loss: Holistic Impacts of a Digital Weight Management Programme Integrating Tirzepatide
2026 · Lena M Sikorska, Vivian N Liu, et al. · Cureus
PDF
Pituitary Axis Impacts and Effectiveness of Clomiphene and Human Chorionic Gonadotropin in Treating Hypogonadism: Cohort Study
2026 · Ashley Kieran Clift, Hans Johnson, et al. · The World Journal of Men s Health
PDF
Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men
2025 · Ashley Kieran Clift, Hans Johnson, et al. · The World Journal of Men s Health
PDF
Author response for "Digital engagement enhances dual GIP / GLP ‐1 receptor agonist and GLP ‐1 receptor agonist efficacy: A retrospective cohort analysis of a digital weight loss service on outcomes and safety"
2025 · Hans Johnson, Ashley Kieran Clift, et al. · Publons reviews and discussion
A Qualitative Exploration of Testosterone Replacement Therapy: Men's Experiences and Healthcare Barriers
2025 · Vivian N. Liu, Hans Johnson, et al. · Trends in Urology & Men s Health
PDF
Tirzepatide in the NHS : The known unknowns of treating obesity at a national scale
2025 · Ashley Kieran Clift, Nadja Auerbach, et al. · Diabetes Obesity and Metabolism
PDF
Longitudinal Improvements in Quality of Life Following Testosterone Replacement Therapy in Men with Biochemical and Symptomatic Testosterone Deficiency: a 12 Month Retrospective Observational Study in a Remote Digital Healthcare Setting in the United Kingdom
2025 · Hans Johnson, Ashley Clift, et al. · Research Square
Author response for "Tirzepatide in the NHS : The known unknowns of treating obesity at a national scale"
2025 · Ashley Kieran Clift, Nadja Auerbach, et al. · Publons reviews and discussion
Works count: 17
Citation count: 149
H-index: 5
I10-index: 3
Year
Topic
Type